HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoko Aoki Selected Research

HLA-DR53

12/2012A naturally processed HLA-DR-bound peptide from the IL-9 receptor alpha of HTLV-1-transformed T cells serves as a T helper epitope.
5/2005Recognition of prostate and breast tumor cells by helper T lymphocytes specific for a prostate and breast tumor-associated antigen, TARP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naoko Aoki Research Topics

Disease

24Neoplasms (Cancer)
11/2021 - 08/2002
6Breast Neoplasms (Breast Cancer)
11/2021 - 08/2002
5Squamous Cell Carcinoma of Head and Neck
01/2019 - 09/2014
5T-Cell Lymphoma (Lymphoma, T Cell)
02/2015 - 12/2005
5Infections
03/2009 - 05/2004
4Lymphoma (Lymphomas)
07/2017 - 12/2005
4Melanoma (Melanoma, Malignant)
06/2017 - 06/2007
2Bites and Stings (Sting)
11/2021 - 06/2017
2Colonic Neoplasms (Colon Cancer)
06/2017 - 03/2016
2Anemia
03/2017 - 02/2008
2Carcinoma (Carcinomatosis)
11/2015 - 05/2008
2T-Cell Leukemia (Leukemia, T Cell)
12/2012 - 06/2006
2Urinary Bladder Neoplasms (Bladder Cancer)
07/2010 - 05/2010
2Inflammation (Inflammations)
06/2009 - 04/2003
2Prostatic Neoplasms (Prostate Cancer)
06/2007 - 05/2005
2Leukemia
07/2006 - 12/2005
1Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2018
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2017
1Hypergammaglobulinemia (Hyperimmunoglobulinemia)
03/2017
1Leukopenia
03/2017
1Proteinuria
03/2017
1Fever (Fevers)
01/2013
1Hamman-Rich Syndrome (Hamman Rich Syndrome)
01/2013
1Dermatomyositis (Dermatopolymyositis)
01/2013
1Dyspnea (Shortness of Breath)
01/2013
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
12/2012
1Lung Neoplasms (Lung Cancer)
11/2011
1Malignant Mesothelioma
05/2011
1Fungal Lung Diseases
01/2011
1Asthma (Bronchial Asthma)
01/2011
1Respiratory Hypersensitivity
01/2011
1Neoplasm Metastasis (Metastasis)
06/2009

Drug/Important Bio-Agent (IBA)

16Peptides (Polypeptides)IBA
01/2019 - 05/2005
16AntigensIBA
01/2019 - 08/2002
14EpitopesIBA
01/2018 - 05/2005
8Proteins (Proteins, Gene)FDA Link
01/2018 - 08/2002
6CytokinesIBA
01/2019 - 05/2004
4LigandsIBA
11/2021 - 02/2015
4T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
11/2011 - 05/2005
4Messenger RNA (mRNA)IBA
03/2009 - 04/2004
3HLA-DR Antigens (HLA-DR)IBA
01/2019 - 09/2014
3VaccinesIBA
12/2012 - 04/2006
3Complementary DNA (cDNA)IBA
12/2007 - 08/2002
2cyclic guanosine monophosphate-adenosine monophosphateIBA
11/2021 - 06/2017
2Monoclonal AntibodiesIBA
01/2019 - 04/2003
2B7-H1 AntigenIBA
01/2019 - 07/2017
2ChemokinesIBA
06/2017 - 01/2017
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2017 - 05/2004
2DNA (Deoxyribonucleic Acid)IBA
03/2017 - 06/2016
2AntibodiesIBA
03/2017 - 07/2006
2Histocompatibility Antigens Class IIIBA
05/2014 - 07/2006
2HLA-DR15 antigenIBA
12/2012 - 05/2005
2HLA-DR53IBA
12/2012 - 05/2005
2MesothelinIBA
05/2011 - 05/2008
2Triggering Receptor Expressed on Myeloid Cells-1IBA
01/2011 - 06/2009
2Membrane Proteins (Integral Membrane Proteins)IBA
05/2010 - 02/2008
2Immunoglobulin G (IgG)IBA
04/2003 - 08/2002
1Transcription Factors (Transcription Factor)IBA
01/2018
1Clodronic Acid (Clodronate)IBA
06/2017
1Dynamins (Dynamin)IBA
06/2017
1bis(3',5')-cyclic diguanylic acidIBA
06/2017
1GTP Phosphohydrolases (GTPases)IBA
06/2017
1Nitric Oxide Synthase (NO Synthase)IBA
06/2017
1Interferon-betaIBA
06/2017
12',5'-Oligoadenylate Synthetase (2',5' Oligoadenylate Synthetase)IBA
06/2017
1Interferon Type IIBA
06/2017
1Liposomes (Liposome)IBA
06/2017
1anti-dsDNA autoantibodyIBA
03/2017
1Immune Checkpoint InhibitorsIBA
01/2017
1HLA-G Antigens (HLA G)IBA
06/2016
1MethyltransferasesIBA
06/2016
1A-Form DNA (A-DNA)IBA
06/2016
1DecitabineFDA Link
06/2016
1ErbB Receptors (EGF Receptor)IBA
03/2016
1Dexamethasone (Maxidex)FDA LinkGeneric
03/2016
1SteroidsIBA
03/2016
1Cetuximab (Erbitux)FDA Link
03/2016
1Oncogene Proteins (Oncogene Protein)IBA
11/2015
1Tyrosine Kinase InhibitorsIBA
11/2015
1Neoplasm Antigens (Tumor Antigens)IBA
09/2014
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
09/2014
1Erlotinib Hydrochloride (CP 358,774)FDA Link
09/2014
1Transforming Growth Factor beta (TGF-beta)IBA
09/2014
1Dinoprostone (PGE2)FDA Link
09/2014
1Lysine (L-Lysine)FDA Link
05/2014
1Histone Deacetylase InhibitorsIBA
05/2014
1Neoplasm AntibodiesIBA
05/2014
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2013
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2013
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2013
1Interleukin-9 Receptors (Interleukin 9 Receptor)IBA
12/2012
1Enhancer of Zeste Homolog 2 ProteinIBA
11/2011
1Polycomb-Group ProteinsIBA
11/2011
1Methacholine Chloride (Methacholine)FDA Link
01/2011
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
07/2010
1Aurora Kinase AIBA
07/2010

Therapy/Procedure

19Immunotherapy
11/2021 - 08/2002
7Therapeutics
11/2021 - 01/2013
1Drug Therapy (Chemotherapy)
01/2018
1Ligation
06/2009